Description
About Wegovy (Semaglutide) Injections
| Medication Name | Wegovy Weekly Injection |
| Active Ingredient | Semaglutide |
| Medication form | Pre-filled Injection |
| Used to treat | Diabetes Weight Loss |
| Available dosages | Pre-filled, single-dose pen delivers doses of 0.25 mg, 0.5 mg, 1 mg, 1.7 mg or 2.4 mg |
| Other names by which this medication is known | Weekly Weight Loss Pen Semaglutide Injections |
| Common side effects | Nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, gas, stomach flu and heartburn. |
| Who is this medication suitable for | Adults over the age of 18 with: – BMI of 30 or more (obesity) or – BMI of 27 or more (overweight) in the presence of at least one weight-related comorbid condition, such as high blood pressure, type 2 diabetes and dyslipidemia |
| Do you need a prescription for it? | Yes |
| How should it be used? | Use once a week on the same day each week |
fter passing rigorous clinical trials to assess its safety and efficiency, Wegovy was approved by the FDA in 2021 for chronic weight management.
Wegovy for Obesity
Obesity is a global health concern. It affects millions of people worldwide and increases the risk of health conditions like diabetes and heart disease.
Losing weight is not always achievable for overweight individuals. Many don’t see results with traditional methods like dieting and exercise. Now, they can order Wegovy online and manage their weight.
Some potential benefits of using Wegovy for obesity include:
- Improving insulin sensitivity
- Regulating cholesterol levels
- Seeing remarkable weight loss results
- Addressing comorbidities such as blood pressure
- Boosting self-esteem and improving overall well-being
How Does Wegovy Work?
The active ingredient of the prescription drug Wegovy is semaglutide. This ingredient mimics a naturally occurring hormone called glucagon-like peptide-1 (GLP-1), which regulates appetite, glucose metabolism, and insulin secretion after food consumption.
By emulating the body’s natural processes, Wegovy can help obese patients lose up to 15% of their body weight.
Wegovy stimulates GLP-1 receptors in your brain. It exerts its effects through the following routes:
- Increasing insulin and decreasing glucagon secretion by the pancreas
- Reducing appetite by slowing down the emptying of the stomach and signaling satiety to the brain
- Reducing cravings and the pleasure derived from eating high-calorie foods by affecting the brain’s reward system
How to Administer Wegovy
You can administer prescription Wegovy yourself or ask a caregiver to help you. If you decide to self-inject the medication, follow these guidelines:
- Order Wegovy online and check the expiration date to ensure its safety.
- Gather the necessary supplies, including the Wegovy pen, alcohol swabs, and sharps container.
- Choose an injection site (abdomen, thigh, or upper arm).
- Wash your hands thoroughly with soap and warm water.
- Attach a needle to the pen and remove its outer and inner caps.
- Set the pen to the prescribed dosage by turning the dose knob.
- Hold the pen with the needle pointing up and tap it to remove air bubbles.
- Clean the injection site with an alcohol swab, and insert the needle into your skin at a 90-degree angle.
- Push the injection button to release the liquid into your body.
- Carefully remove the needle and dispose of it in the sharps container.
buy Wegovy online dosage and treatment timeline Wegovy is started at a low dose and increased gradually over 16 weeks to reach the maintenance dose of 2.4 mg, helping to minimise the likelihood of side effects. For eligible patients with obesity, the dose may be further increased to 7.2 mg.
| Weeks | Dose | What this stage is for | Stage |
|---|---|---|---|
| 1–4 | 0.25 mg once weekly | Starting dose to help your body adjust to treatment | Starter |
| 5–8 | 0.5 mg once weekly | First increase; appetite control may begin to improve further | Titration |
| 9–12 | 1 mg once weekly | Gradual step-up to support continued progress and tolerability | Titration |
| 13–16 | 1.7 mg once weekly | Higher dose for patients who need additional appetite support | Titration |
| 17+ | 2.4 mg once weekly | Standard maintenance dose for ongoing weight management | Maintenance |
| After ≥4 weeks on 2.4 mg | 7.2 mg once weekly | Higher dose for people with obesity (BMI ≥30) to achieve up to ~21% weight loss |
Standard dose resultsAt the standard maintenance dose of Wegovy® 2.4 mg, a separate trial over 68 weeks found patients lost an average of 15–17% of their body weight — compared to around 2% with placebo — alongside a reduced-calorie diet and increased physical activity.Typical weight loss timeline
| Treatment stage | Approximate timeframe | Average weight loss observed* |
|---|---|---|
| Initial dose (0.25 mg → 0.5 mg) | Weeks 1–8 | ~3–5% of body weight |
| Dose escalation (1 mg → 1.7 mg) | Weeks 9–16 | ~6–10% of body weight |
| Maintenance dose (2.4 mg) | Weeks 17–68 | ~16–18% of body weight |
Wegovy Medication Table
| Forms | Wegovy is available as a pre-filled, single-dose pen for subcutaneous injection. |
| Usage | Adults: Chronic weight management in obese adults (BMI ≥30) or overweight adults (BMI ≥27) with at least one weight-related comorbidity. Adolescents (12–17 years): Weight management in patients with obesity (body weight >60 kg and BMI ≥30). |
| Mechanism of Action | GLP-1 receptor agonist – increases insulin release, decreases glucagon, reduces appetite by slowing gastric emptying and affecting the brain’s reward system. |
| Administration Method | Subcutaneous injection once weekly (abdomen, thigh, or upper arm), at any time of day with or without food. |
| Strengths & Dosages | Available in 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg doses. Start with 0.25 mg once weekly, increase to 0.5 mg after 4 weeks, and gradually increase to 2.4 mg. |
| Missed Dose | If missed, inject within 5 days of the missed dose. If more than 5 days late, skip the missed dose and resume your normal schedule. |
| Overdose | Symptoms may include nausea, vomiting, diarrhea, and signs of hypoglycemia. Seek immediate medical attention if overdose is suspected. |
| Storage | Store in the refrigerator (2°C–8°C). Do not freeze. Once in use, Wegovy can be kept at room temperature (<30°C) for up to 30 days. |
| Side Effects | Common: Nausea, vomiting, diarrhea, constipation, abdominal pain, headache, dizziness. Serious (rare): Pancreatitis, gallbladder issues, hypoglycemia, thyroid tumors, liver problems, suicidal ideation. |
| Drug Interactions | May interact with antidiabetic medications (increased risk of hypoglycemia), and delayed gastric emptying can affect the absorption of oral medications. |
Reviews
There are no reviews yet.